Trial Profile
Tolerability and pharmacokinetics of RG 7348 in volunteers and preliminary efficacy in patients with hepatitis C
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Apr 2012
Price :
$35
*
At a glance
- Drugs RG 7348 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Roche
- 22 Apr 2012 Results presented at the 113th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 22 Apr 2010 New trial record